4-Hydroxyphenylpyruvate Dioxygenase (HPD) (Middle Region) Peptide
HPD
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all HPD products
- HPD (4-Hydroxyphenylpyruvate Dioxygenase (HPD))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-HPD antibody (Catalog #: ARP41493_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- HPD (4-Hydroxyphenylpyruvate Dioxygenase (HPD))
- Background
-
The protein encoded by this gene is an enzyme in the catabolic pathway of tyrosine. The encoded protein catalyzes the conversion of 4-hydroxyphenylpyruvate to homogentisate. Defects in this gene are a cause of tyrosinemia type 3 (TYRO3) and hawkinsinuria
Alias Symbols: 4-HPPD, 4HPPD, GLOD3, PPD, HPPDASE
Protein Size: 393 - Molecular Weight
- 45 kDa
- Gene ID
- 3242
- NCBI Accession
- NM_002150, NP_002141
- UniProt
- P32754
-
You are here:
